Alan Schatzberg

8PUBLICATIONS
23CO-AUTHORS
Molecular medicineCognitionGene and molecular therapyPsychopharmacologyNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 19, 2026
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

|Nov 10, 2025
A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.

Laura M Hack, Jenna Jubeir, Rachel Hilton

|Mar 10, 2025
A Stratified Precision Medicine Trial Targeting Selective Mechanisms of Alpha 2A Agonism as a Treatment for the Cognitive Biotype of Depression: The BIomarker Guided (BIG) Study for Depression.

Leanne Williams, Laura Hack, Jenna Jubeir

|Oct 14, 2024
Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine Trial.

Theresa R Lii, Josephine R Flohr, Robin L Okada

|Apr 08, 2023
Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia.

Adriana M Medina, Megan Hastings Hagenauer, David M Krolewski

|Aug 30, 2022
Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder.

Sujan C Das, Brooke E Hjelm, Brandi L Rollins

Pageof 2

Frequent Collaborators

3 joint publications

Francis S Lee

3 joint publications

P Adolfo Sequeira

2 joint publications

Leanne Williams

2 joint publications

Stanley J Watson